Print

Sirion Therapeutics U.S. Rights for Eye Treatment to Bausch & Lomb (BOL)  
6/3/2010 8:15:01 AM

Tampa Bay Business Journal -- Bausch & Lomb acquired the assets and U.S. rights for Zirgan from Sirion Therapeutics Inc. Financial terms were not disclosed in a release announcing the deal.
//-->